Chemist 3/Senior Chemist Raw Materials
MedPharm
Chemist 3/Senior Chemist Raw Materials
MedPharm
Topical and transdermal drug delivery CDMO
Position Summary – The Chemist III/Sr. Chemist Raw Materials ensures that testing, data review, and documentation is compliant with GMP regulations, internal procedures, and applicable compendial requirements. The position will be operating within a GMP environment for a Quality Control CDMO. The ideal candidate will additionally possess superior communication skills, presenting to internal and external clients
Essential Functions
Supervisory responsibilities
Key Relationships
Travel requirements:
Education and Experience
Knowledge, Skills, and Abilities
Physical Demands and Work Environment
While performing the duties of this job, there may be certain physical demands required for the position.
Other Duties
You may be asked to take on any other responsibilities or tasks that are within your skills and abilities whenever reasonably asked.
Limitations and Disclaimer
The above job description is meant to describe the general nature and level of work being performed; it is not intended to be construed as an exhaustive list of all responsibilities, duties, and skills required for the position. The Company is committed to making reasonable adjustments to the workplace to ensure the role is accessible to all candidates, including those with disabilities. To perform the job successfully, the employee must possess the abilities or aptitudes to perform each duty proficiently.
MedPharm is a contract development and manufacturing organization focused on topical, transdermal, and mucosal drug delivery. It provides end-to-end services from formulation development through clinical and commercial manufacturing, including analytical testing and regulatory support, and operates proprietary delivery platforms such as MedSpray, MedTherm, and AquaRMed to enable multiple administration routes. The company combines contract research with a patent portfolio and offers lifecycle support across development and manufacturing, differentiating itself from competitors. A July 2024 merger with Tergus Pharma expanded capabilities to include hormone-based and highly potent drugs, enhancing scale and scope with the aim of helping pharma and biotech move products from early formulation to scalable manufacturing.
Explore more opportunities at MedPharm